Market Overview

Heat Biologics Shares React Amid Circulation Of PatentScope Doc


Heat Biologics Inc (NASDAQ: HTBX) shares traded sharply higher after the circulation of a document from the World Intellectual Property Organization's PatentScope highlighting lung cancer treatment.

The document circulated is a patent granted for “GP96-based cancer therapy” by Heat Biologics and contains the following:

"The present disclosure relates, inter alia, to compositions and methods for treating cancer, including lung cancer (e.g., Non-Small Cell Lung Cancer), comprising administering (a) a cell harboring an expression vector comprising a nucleotide sequence that encodes a secretable vaccine protein and (b) an immune checkpoint inhibitor to a subject in need thereof."

Heat Biologics traded up 18 percent to 85 cents per share at time of publication Friday afternoon.

Related Links:

Why Stellar Biotech Shares Are Up 70%

Low-Float Du Jour: Genocea Biosciences

Posted-In: Biotech News Penny Stocks Rumors Legal Markets General


Related Articles (HTBX)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

CBI Tells Tory Leadership Hopefuls To Show "A Bold And Compelling Vision" Of Britain's Future

Lucrative Investments In Angolan Economic Sectors